1. Home
  2. LSCC vs RGEN Comparison

LSCC vs RGEN Comparison

Compare LSCC & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lattice Semiconductor Corporation

LSCC

Lattice Semiconductor Corporation

HOLD

Current Price

$75.13

Market Cap

9.6B

Sector

Technology

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$162.51

Market Cap

8.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LSCC
RGEN
Founded
1983
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.6B
8.2B
IPO Year
1989
N/A

Fundamental Metrics

Financial Performance
Metric
LSCC
RGEN
Price
$75.13
$162.51
Analyst Decision
Strong Buy
Buy
Analyst Count
11
10
Target Price
$76.18
$174.90
AVG Volume (30 Days)
1.9M
701.7K
Earning Date
02-09-2026
10-28-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.20
0.03
Revenue
$494,889,000.00
$707,890,000.00
Revenue This Year
$4.23
$17.84
Revenue Next Year
$21.23
$12.57
P/E Ratio
$378.13
$5,259.20
Revenue Growth
N/A
11.74
52 Week Low
$34.69
$102.97
52 Week High
$81.23
$182.52

Technical Indicators

Market Signals
Indicator
LSCC
RGEN
Relative Strength Index (RSI) 55.89 54.15
Support Level $71.27 $156.01
Resistance Level $79.97 $165.02
Average True Range (ATR) 3.31 4.65
MACD -0.30 -1.07
Stochastic Oscillator 50.17 43.33

Price Performance

Historical Comparison
LSCC
RGEN

About LSCC Lattice Semiconductor Corporation

Lattice Semiconductor Corp is a developer of semiconductor technology that it distributes through products, solutions, and licenses. The company reaches its customers through consumer, communications, and industrial markets. The company has one operating segment namely the core Lattice business that includes silicon-based and silicon-enabling products, evaluation boards, development hardware, and related intellectual property licensing, services, and sales. The products of the company are offered globally; and, the majority of sales are derived from customers in Asia. It also has its presence in Americas and Europe.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: